Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update

Published:2024-06-14 Issue: Volume: Page:1-13
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Winograd Joshua¹^ORCID,Venishetty Nikit²,Codelia-Anjum Alia¹,Bhojani Naeem³,Elterman Dean⁴,Zorn Kevin C.³,Te Alexis¹,Chughtai Bilal¹

Affiliation:

1. Department of Urology, Weill Cornell Medicine, New York, NY, USA

2. Paul L. Foster School of Medicine, Texas Tech Health Sciences Center, El Paso, TX, USA

3. Division of Urology, University of Montreal, Montreal, Québec, Canada

4. Division of Urology, University of Toronto, Toronto, Ontario, Canada

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2024.2363213

Reference121 articles.

1. The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management

2. Benign prostatic hyperplasia

3. Natural History and Epidemiology of Benign Prostatic Hyperplasia: Relationship Among Urologic Measures

4. Roehrborn CG. Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Chapter 38. In: Roehrborn C, and McConnel J. Campbell’s Urology. 8th ed. W. B. Saunders Company; 2002. p. 1297–1330.

5. Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP